Sotorasib 120 mg in India for Cancer Treatment, New Delhi

Sotorasib tablet also known by its brand name Lumakras, is a precision medicine specifically designed to target a common genetic mutation found in non-small cell lung cancer (NSCLC) – the KRAS G12C mutation. This mutation, previously considered "undruggable," now has a targeted therapy that directly inhibits the mutated protein. It hinders tumor growth and progression. Sotorasib 120 mg in India offers a newfound hope and optimism for the treatment of NSCLC. Unlike traditional chemotherapy, it is well-tolerated, with manageable side effects that allow patients to maintain their health while undergoing treatment. Impomed Healthcare strives to empower patients with this drug to combat cancer and reclaim their health and well-being.